6-Fluoro-AMT
From Wikipedia, the free encyclopedia
 | |
|---|---|
| Systematic (IUPAC) name | |
| 1-(6-fluoro-1H-indol-3-yl)propan-2-amine | |
| Clinical data | |
| Legal status | ? |
| Identifiers | |
| CAS number | 712-11-8  |
| ATC code | ? |
| PubChem | CID 15289992 |
| Chemical data | |
| Formula | C11H13FN2 |
| Mol. mass | 192.23 g/mol |
| |
6-Fluoro-α-methyltryptamine (6-fluoro-AMT) is a tryptamine derivative related to compounds such as alpha-methyltryptamine and 5-MeO-AMT, which has been sold as a designer drug. Animal tests showed it to be somewhat less active than AMT or 5-fluoro-AMT,[1] but it was nevertheless allegedly manufactured and sold from the laboratory operated by Leonard Pickard and Gordon Todd Skinner, who described 6-fluoro-AMT as "a beast".[2]
See also
References
- ↑ Kalir, A.; Szara, S. (1963). Journal of Medicinal Chemistry 6 (6): 716. doi:10.1021/jm00342a019.
- ↑ Life is a Cosmic Giggle on the Breath of the Universe. A Tour of Gordon Todd Skinner's Subterranean LSD Palace. Hamilton Morris, Vice Magazine 2010
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.